Literature DB >> 10757382

Splenectomy in patients with hepatocellular carcinoma and hypersplenism.

Y Sugawara1, J Yamamoto, K Shimada, S Yamasaki, T Kosuge, T Takayama, M Makuuchi.   

Abstract

BACKGROUND: Hypersplenism secondary to portal hypertension is common in hepatocellular carcinoma (HCC), but surgeons still face the unresolved problem of how to manage HCC patients with hypersplenism. STUDY
DESIGN: The records of 48 patients with HCC and hypersplenism were retrospectively examined and postoperative changes in platelet counts, serum total bilirubin levels, and dinical staging scores were analyzed to evaluate the clinical value of combined splenectomy and liver resection. Hepatectomy and splenectomy were performed as a two-stage operation in 13 patients and synchronously in 35.
RESULTS: Postoperative platelet counts were significantly increased, and serum total bilirubin levels were significantly decreased. Clinical staging scores were also reduced after splenectomy in patients who underwent splenectomy before hepatectomy.
CONCLUSIONS: Synchronous or metachronous splenectomy can increase the safety of hepatectomy in selected patients with HCC by reducing both the likelihood of bleeding complications and bilirubin overload.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10757382     DOI: 10.1016/s1072-7515(99)00294-x

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  37 in total

1.  Traumatic splenectomy in a cirrhotic patient with hepatitis C and alcoholic liver disease.

Authors:  Hosam E Matar; Ashraf S Elmetwally; Manojkumar S Nair; Rudi Borgstein; Olu Oluwajobi
Journal:  BMJ Case Rep       Date:  2012-01-03

2.  Long-term postoperative outcomes of hypersplenism: laparoscopic versus open splenectomy secondary to liver cirrhosis.

Authors:  Jin Zhou; Zhong Wu; Prasoon Pankaj; Bing Peng
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

Review 3.  Management before hepatectomy for hepatocellular carcinoma with cirrhosis.

Authors:  Hisashi Nakayama; Tadatoshi Takayama
Journal:  World J Hepatol       Date:  2015-09-18

4.  Migration of splenic lymphocytes promotes liver fibrosis through modification of T helper cytokine balance in mice.

Authors:  Kazutaka Tanabe; Kojiro Taura; Yukinori Koyama; Gen Yamamoto; Takahiro Nishio; Yukihiro Okuda; Kojiro Nakamura; Kan Toriguchi; Kenji Takemoto; Kenya Yamanaka; Keiko Iwaisako; Satoru Seo; Masataka Asagiri; Etsuro Hatano; Shinji Uemoto
Journal:  J Gastroenterol       Date:  2015-02-28       Impact factor: 7.527

5.  Portal hypertension: contraindication to liver surgery?

Authors:  Lorenzo Capussotti; Alessandro Ferrero; Luca Viganò; Andrea Muratore; Roberto Polastri; Hedayat Bouzari
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

6.  Synchronous splenectomy and hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A case-control study.

Authors:  Xiao-Yun Zhang; Chuan Li; Tian-Fu Wen; Lu-Nan Yan; Bo Li; Jia-Yin Yang; Wen-Tao Wang; Li Jiang
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

7.  A novel method for laparoscopic splenectomy in the setting of hypersplenism secondary to liver cirrhosis: ten years' experience.

Authors:  Yunqiang Cai; Xubao Liu; Bing Peng
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

8.  Effect of thrombopoietin on platelet counts and liver regeneration after partial hepatectomy in a rat model.

Authors:  Rinshun Shimabukuro; Hirofumi Kawanaka; Morimasa Tomikawa; Tomohiko Akahoshi; Kozo Konishi; Daisuke Yoshida; Go Anegawa; Hideo Uehara; Naotaka Hashimoto; Makoto Hashizume; Yoshihiko Maehara
Journal:  Surg Today       Date:  2009-12-08       Impact factor: 2.549

9.  Surgical treatment of hepatocellular carcinoma with cirrhotic esophageal varices and hypersplenism: a 184 case report.

Authors:  Bin Jiang; Xiaoping Chen; Zhiyong Huang; Zhiwei Zhang; Songqing He; Shaofa Wang; Zaide Wu; Fazu Qiu
Journal:  Front Med China       Date:  2007-02-01

10.  Simultaneous microwave coagulo-necrotic therapy (MCN) and laparoscopic splenectomy for the treatment of hepatocellular carcinoma with cirrhotic hypersplenism.

Authors:  Tomoki Ryu; Yuko Takami; Norifumi Tsutsumi; Masaki Tateishi; Kazuhiro Mikagi; Yoshiyuki Wada; Hideki Saitsu
Journal:  Surg Today       Date:  2016-08-30       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.